These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
676 related items for PubMed ID: 29161812
1. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms. Wei IH, Chen KT, Tsai MH, Wu CH, Lane HY, Huang CC. J Agric Food Chem; 2017 Dec 13; 65(49):10792-10803. PubMed ID: 29161812 [Abstract] [Full Text] [Related]
2. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests. Andreasen JT, Gynther M, Rygaard A, Bøgelund T, Nielsen SD, Clausen RP, Mogensen J, Pickering DS. Neurosci Lett; 2013 Jun 24; 546():6-10. PubMed ID: 23643996 [Abstract] [Full Text] [Related]
3. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR. Akinfiresoye L, Tizabi Y. Psychopharmacology (Berl); 2013 Nov 24; 230(2):291-8. PubMed ID: 23732839 [Abstract] [Full Text] [Related]
4. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice. Shen M, Lv D, Liu X, Li S, Chen Y, Zhang Y, Wang Z, Wang C. Brain Res Bull; 2018 Oct 24; 143():58-65. PubMed ID: 30316917 [Abstract] [Full Text] [Related]
5. Potential link between antidepressant-like effects of ketamine and promotion of adult neurogenesis in the ventral hippocampus of mice. Yamada J, Jinno S. Neuropharmacology; 2019 Nov 01; 158():107710. PubMed ID: 31310776 [Abstract] [Full Text] [Related]
6. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ. Eur Psychiatry; 2014 Sep 01; 29(7):419-23. PubMed ID: 24321772 [Abstract] [Full Text] [Related]
7. Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites. Yang C, Yang J, Luo A, Hashimoto K. Transl Psychiatry; 2019 Nov 07; 9(1):280. PubMed ID: 31699965 [Abstract] [Full Text] [Related]
8. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, Quevedo J. Behav Brain Res; 2011 Aug 01; 221(1):166-71. PubMed ID: 21397634 [Abstract] [Full Text] [Related]
9. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine. Yang C, Kobayashi S, Nakao K, Dong C, Han M, Qu Y, Ren Q, Zhang JC, Ma M, Toki H, Yamaguchi JI, Chaki S, Shirayama Y, Nakazawa K, Manabe T, Hashimoto K. Biol Psychiatry; 2018 Oct 15; 84(8):591-600. PubMed ID: 29945718 [Abstract] [Full Text] [Related]
10. TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats. Suzuki A, Murakami K, Tajima Y, Hara H, Kunugi A, Kimura H. Pharmacol Biochem Behav; 2019 Aug 15; 183():80-86. PubMed ID: 31202810 [Abstract] [Full Text] [Related]
11. AMPA Receptor-mTOR Activation is Required for the Antidepressant-Like Effects of Sarcosine during the Forced Swim Test in Rats: Insertion of AMPA Receptor may Play a Role. Chen KT, Tsai MH, Wu CH, Jou MJ, Wei IH, Huang CC. Front Behav Neurosci; 2015 Aug 15; 9():162. PubMed ID: 26150775 [Abstract] [Full Text] [Related]
12. Acute D-serine treatment produces antidepressant-like effects in rodents. Malkesman O, Austin DR, Tragon T, Wang G, Rompala G, Hamidi AB, Cui Z, Young WS, Nakazawa K, Zarate CA, Manji HK, Chen G. Int J Neuropsychopharmacol; 2012 Sep 15; 15(8):1135-48. PubMed ID: 21906419 [Abstract] [Full Text] [Related]
13. Ifenprodil rapidly ameliorates depressive-like behaviors, activates mTOR signaling and modulates proinflammatory cytokines in the hippocampus of CUMS rats. Yao Y, Ju P, Liu H, Wu X, Niu Z, Zhu Y, Zhang C, Fang Y. Psychopharmacology (Berl); 2020 May 15; 237(5):1421-1433. PubMed ID: 32130432 [Abstract] [Full Text] [Related]
14. Natural product Kaji-ichigoside F1 exhibits rapid antidepression via activating the AMPA-BDNF-mTOR pathway and inhibiting the NMDAR-CaMKIIα pathway. Chen F, Li L, Huang M, Wang Y, Wang L, Jin F, Yang L, Gao M, Li L, Wang Y, Zhou L, Yang J, Yao G, Li Q, Yang X. Phytomedicine; 2024 Apr 15; 126():155452. PubMed ID: 38422650 [Abstract] [Full Text] [Related]
15. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats. Hara H, Suzuki A, Kunugi A, Tajima Y, Yamada R, Kimura H. Pharmacol Biochem Behav; 2021 Dec 15; 211():173289. PubMed ID: 34655652 [Abstract] [Full Text] [Related]
16. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice. Lindholm JS, Autio H, Vesa L, Antila H, Lindemann L, Hoener MC, Skolnick P, Rantamäki T, Castrén E. Neuropharmacology; 2012 Jan 15; 62(1):391-7. PubMed ID: 21867718 [Abstract] [Full Text] [Related]
17. Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons. El Iskandrani KS, Oosterhof CA, El Mansari M, Blier P. J Psychopharmacol; 2015 Jul 15; 29(7):792-801. PubMed ID: 25759403 [Abstract] [Full Text] [Related]
18. Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses. Gideons ES, Kavalali ET, Monteggia LM. Proc Natl Acad Sci U S A; 2014 Jun 10; 111(23):8649-54. PubMed ID: 24912158 [Abstract] [Full Text] [Related]
19. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Garcia LS, Comim CM, Valvassori SS, Réus GZ, Andreazza AC, Stertz L, Fries GR, Gavioli EC, Kapczinski F, Quevedo J. Basic Clin Pharmacol Toxicol; 2008 Dec 10; 103(6):502-6. PubMed ID: 19067677 [Abstract] [Full Text] [Related]
20. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats. Podkowa K, Pochwat B, Brański P, Pilc A, Pałucha-Poniewiera A. Psychopharmacology (Berl); 2016 Aug 10; 233(15-16):2901-14. PubMed ID: 27286960 [Abstract] [Full Text] [Related] Page: [Next] [New Search]